Summary of Key Information:
Reporting Period (Quarter/Year): Not Applicable
Nature of Filing / Announcement: Outcome of Board Meeting under Regulation 30 of SEBI (LODR) Regulations, 2015
Audit Opinion:
Not Specified
Key Financial Highlights:
Not Specified
Standalone Results:
Not Specified
Consolidated Results:
Not Specified
Segment-wise Performance:
Not Specified
Corporate Actions:
The Board approved the following corporate actions:
1. Preferential Share Issue (Share Swap) for WEXL Edu Acquisition:
- Approval for issuance of up to 1,197,080,040 equity shares of face value ₹1 each
- Issue price: ₹1 per share
- Share swap ratio: 120 equity shares of GACM Technologies for 1 equity share of WEXL Edu Limited
- Total enterprise value: ₹119.71 crores for 22.18% stake acquisition
- Allocation to 164 allottees (non-promoters) as per detailed table in annexure
- Lock-in period as per SEBI ICDR Regulations Chapter V
- Relevant date for price determination: August 31, 2026
2. Subsidiary Incorporation:
- Decision to incorporate wholly-owned foreign subsidiary in Hong Kong (GACM Tech HK Limited)
- Share capital: 25,000 ordinary shares of HKD 1 each
- Business: Software Development, Information Technologies
- Previous decision to incorporate in UK (dated June 25, 2026) was reconsidered as unviable
3. Dividend Declarations:
Not Specified
Other Significant Information:
1. Shareholding Pattern Impact:
- Pre-issue paid-up capital: 1,597,742,236 equity shares
- Post-issue fully diluted capital: 2,794,822,276 equity shares
- Promoter holding reduces from 0.63% to 0.36%
- Public holding increases from 99.37% to 99.64%
- No change in control post-issue
2. Transaction Details:
- Acquisition of 9,975,667 equity shares of WEXL Edu Limited
- WEXL Edu Limited described as "fast-growing education technology firm engaged in delivering AI-enabled academic solutions across India"
- Strategic rationale: "integrate and strengthen the supply chain for company's Infrastructural"
3. Timeline:
- Preferential allotment to be completed within 15 days of shareholder approval
- Extension allowed if regulatory approvals are pending